Free tool
FAERS Monitor: Isolyte S Ph 7.4 In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019696 or its brand name (Isolyte S Ph 7.4 In Plastic Container, Magnesium Chloride, Potassium Chloride, Potassium Phosphate, Monobasic, Sodium Acetate, Sodium Chloride, Sodium Gluconate, Sodium Phosphate, Dibasic, Heptahydrate). Reports on generic versions are filed under their own applications.
Reports
17
Serious
17
100% of reports
Hospitalization
0
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- atrial fibrillation9
- bradycardia8
- caesarean section1
- exposure during pregnancy1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 17 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| bradycardiaSignal | 8 | 186.7 | 112.8 | 1,301 |
| atrial fibrillationSignal | 9 | 114.3 | 73.0 | 905 |
| caesarean section | 1 | 106.2 | 15.9 | 26 |
| exposure during pregnancy | 1 | 19.9 | 3.0 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.